These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15492512)

  • 1. A model for CDK2 in maintaining genomic stability.
    Zhu Y
    Cell Cycle; 2004 Nov; 3(11):1358-62. PubMed ID: 15492512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CDK2 inhibition modifies the dynamics of chromatin-bound minichromosome maintenance complex and replication protein A.
    Zhu Y; Ishimi Y; Tanudji M; Lees E
    Cell Cycle; 2005 Sep; 4(9):1254-63. PubMed ID: 16082227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-S-phase checkpoint activation by direct CDK2 inhibition.
    Zhu Y; Alvarez C; Doll R; Kurata H; Schebye XM; Parry D; Lees E
    Mol Cell Biol; 2004 Jul; 24(14):6268-77. PubMed ID: 15226429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins.
    Savio M; Cerri M; Cazzalini O; Perucca P; Stivala LA; Pichierri P; Franchitto A; Meijer L; Prosperi E
    Cell Cycle; 2006 Sep; 5(18):2153-9. PubMed ID: 16969115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A p53-dependent checkpoint pathway prevents rereplication.
    Vaziri C; Saxena S; Jeon Y; Lee C; Murata K; Machida Y; Wagle N; Hwang DS; Dutta A
    Mol Cell; 2003 Apr; 11(4):997-1008. PubMed ID: 12718885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation.
    Hughes BT; Sidorova J; Swanger J; Monnat RJ; Clurman BE
    Proc Natl Acad Sci U S A; 2013 May; 110(22):8954-9. PubMed ID: 23671119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin licensing and p53 status regulate Cdk2 activity during G(1).
    Nevis KR; Cordeiro-Stone M; Cook JG
    Cell Cycle; 2009 Jun; 8(12):1952-63. PubMed ID: 19440053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells.
    Lin ML; Lu YC; Su HL; Lin HT; Lee CC; Kang SE; Lai TC; Chung JG; Chen SS
    J Cell Biochem; 2011 Apr; 112(4):1176-91. PubMed ID: 21308745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response.
    Liu Q; Gao J; Zhao C; Guo Y; Wang S; Shen F; Xing X; Luo Y
    DNA Repair (Amst); 2020 Jan; 85():102702. PubMed ID: 31731257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
    Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
    Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.
    Linzen U; Lilischkis R; Pandithage R; Schilling B; Ullius A; Lüscher-Firzlaff J; Kremmer E; Lüscher B; Vervoorts J
    PLoS One; 2015; 10(4):e0123736. PubMed ID: 25860957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cdk2-c-Myc-miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting Geminin.
    Zhang Y; Li Z; Hao Q; Tan W; Sun J; Li J; Chen CW; Li Z; Meng Y; Zhou Y; Han Z; Pei H; DePamphilis ML; Zhu W
    Cancer Res; 2019 Oct; 79(19):4896-4910. PubMed ID: 31431461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage.
    Bačević K; Lossaint G; Achour TN; Georget V; Fisher D; Dulić V
    Sci Rep; 2017 Oct; 7(1):13429. PubMed ID: 29044141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells.
    Yang TY; Chang GC; Chen KC; Hung HW; Hsu KH; Sheu GT; Hsu SL
    Eur J Pharmacol; 2011 Aug; 663(1-3):17-26. PubMed ID: 21575631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms.
    King C; Diaz HB; McNeely S; Barnard D; Dempsey J; Blosser W; Beckmann R; Barda D; Marshall MS
    Mol Cancer Ther; 2015 Sep; 14(9):2004-13. PubMed ID: 26141948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells.
    Lunn CL; Chrivia JC; Baldassare JJ
    Cell Cycle; 2010 Nov; 9(22):4533-41. PubMed ID: 21088490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the ATR/Chk1 pathway induces a p38-dependent S-phase delay in mouse embryonic stem cells.
    Jirmanova L; Bulavin DV; Fornace AJ
    Cell Cycle; 2005 Oct; 4(10):1428-34. PubMed ID: 16138010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.
    Huang H; Regan KM; Lou Z; Chen J; Tindall DJ
    Science; 2006 Oct; 314(5797):294-7. PubMed ID: 17038621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.